Clezardin P - Search Results

1

Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis.

Hinz N, Baranowsky A, Horn M, Kriegs M, Sibbertsen F, Smit DJ, Clezardin P, Lange T, Schinke T, Jücker M. Hinz N, et al. Among authors: clezardin p. Cells. 2021 Feb 18;10(2):430. doi: 10.3390/cells10020430. Cells. 2021. PMID: 33670586 Free PMC article.

2

Bone metastasis: pathogenesis and therapeutic implications.

Clezardin P, Teti A. Clezardin P, et al. Clin Exp Metastasis. 2007;24(8):599-608. doi: 10.1007/s10585-007-9112-8. Epub 2007 Nov 16. Clin Exp Metastasis. 2007. PMID: 18008175 Review.

3

TWIST1 expression in breast cancer cells facilitates bone metastasis formation.

Croset M, Goehrig D, Frackowiak A, Bonnelye E, Ansieau S, Puisieux A, Clézardin P. Croset M, et al. Among authors: clezardin p. J Bone Miner Res. 2014 Aug;29(8):1886-99. doi: 10.1002/jbmr.2215. J Bone Miner Res. 2014. PMID: 24619707 Free article.

4

Bone metastases.

Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M, Guise T, Colangeli S, Capanna R, Costa L. Coleman RE, et al. Among authors: clezardin p. Nat Rev Dis Primers. 2020 Oct 15;6(1):83. doi: 10.1038/s41572-020-00216-3. Nat Rev Dis Primers. 2020. PMID: 33060614 Review.

5

Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions.

Pantano F, Croset M, Driouch K, Bednarz-Knoll N, Iuliani M, Ribelli G, Bonnelye E, Wikman H, Geraci S, Bonin F, Simonetti S, Vincenzi B, Hong SS, Sousa S, Pantel K, Tonini G, Santini D, Clézardin P. Pantano F, et al. Among authors: clezardin p. Oncogene. 2021 Feb;40(7):1284-1299. doi: 10.1038/s41388-020-01603-6. Epub 2021 Jan 8. Oncogene. 2021. PMID: 33420367 Free PMC article.

6

MicroRNAs and Their Roles in Breast Cancer Bone Metastasis.

Puppo M, Valluru MK, Clézardin P. Puppo M, et al. Among authors: clezardin p. Curr Osteoporos Rep. 2021 Jun;19(3):256-263. doi: 10.1007/s11914-021-00677-9. Epub 2021 Apr 8. Curr Osteoporos Rep. 2021. PMID: 33830428 Free PMC article. Review.

7

Additive antitumor activities of taxoids in combination with the bisphosphonate ibandronate against invasion and adhesion of human breast carcinoma cells to bone.

Magnetto S, Boissier S, Delmas PD, Clezardin P. Magnetto S, et al. Among authors: clezardin p. Int J Cancer. 1999 Oct 8;83(2):263-9. doi: 10.1002/(sici)1097-0215(19991008)83:2<263::aid-ijc19>3.0.co;2-t. Int J Cancer. 1999. PMID: 10471537 Free article.

8

Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions.

Peyruchaud O, Winding B, Pécheur I, Serre CM, Delmas P, Clézardin P. Peyruchaud O, et al. Among authors: clezardin p. J Bone Miner Res. 2001 Nov;16(11):2027-34. doi: 10.1359/jbmr.2001.16.11.2027. J Bone Miner Res. 2001. PMID: 11697798 Free article.

9

Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone.

Pécheur I, Peyruchaud O, Serre CM, Guglielmi J, Voland C, Bourre F, Margue C, Cohen-Solal M, Buffet A, Kieffer N, Clézardin P. Pécheur I, et al. Among authors: clezardin p. FASEB J. 2002 Aug;16(10):1266-8. doi: 10.1096/fj.01-0911fje. Epub 2002 Jun 21. FASEB J. 2002. PMID: 12153995

10

In vitro and in vivo antitumor effects of bisphosphonates.

Clézardin P, Fournier P, Boissier S, Peyruchaud O. Clézardin P, et al. Curr Med Chem. 2003 Jan;10(2):173-80. doi: 10.2174/0929867033368529. Curr Med Chem. 2003. PMID: 12570716 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

173 results

Search Page